Navigation Links
Transdel Pharmaceuticals Presents Phase 3 Study Data on Ketotransdel® at World Pain Congress in Montreal, Canada
Date:9/2/2010

related cutaneous/application site adverse events was slightly lower with TDLP-110 (1.1% vs. placebo 2.2%, respectively). There were no clinically relevant shifts from baseline in laboratory parameters (hematology, coagulation, serum chemistry, and urinalysis). The estimated systemic absorption of TDLP-110 is about 1 - 2 % of a comparable oral ketoprofen dose. In a pharmacokinetic sub-study of this Phase 3 trial minimal blood concentrations (mean Cmax 39.0 ng/mL) of ketoprofen were measured at steady-state, which is consistent with previous Phase 1/2 study findings. This Phase 3 study (TDLP-110-001) demonstrated that TDLP-110 was more effective than placebo in reducing pain of acute soft tissue injuries and was very well tolerated.

"Today's presentation of our data at the world's premier congress devoted to research and treatment of pain is a significant event for our company," stated Joachim Schupp, M.D., Chief Medical Officer at Transdel Pharmaceuticals. "We believe that study TDLP-110-001 could serve as one of two required confirmatory trials of evidence of efficacy for TDLP-110 and we plan to initiate the second trial upon sufficient funding."

To view the poster presented at the conference, please visit the Company's website at www.transdelpharma.com.

About Transdel Pharmaceuticals, Inc.

Transdel Pharmaceuticals, Inc. (OTCBB: TDLP) is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company's innovative-patented Transdel™ cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier.  Ketotransdel®, the Company's lead pain product candidate, has completed a Phase 3 clinical trial and utilizes the Transdel™ technology to deliver the active drug, ketoprofen, a non-steroidal anti-inflammatory drug through the skin directly into the underlyi
'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Transdel Pharmaceuticals Announces Management Reorganization
2. Transdel Pharmaceuticals to Webcast Presentation at 4th Annual BIOCOM Investor Conference
3. Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial
4. Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain
5. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
6. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
7. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
8. Pfizer to Acquire FoldRx Pharmaceuticals
9. Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China
10. Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015
11. Webcast Alert: Isis Pharmaceuticals Hosts Expert Panel Conference Call to Discuss Mipomersen Data Presented at the ESC Congress 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 According to a new ... (RFID) Market (Tags, Readers, Middleware, Printers and Cabinets) - ... 2014 - 2020" the global radiofrequency identification (RFID) market ... is expected to grow at a CAGR of 13.9% ... of USD 5.3 billion in 2020. Browse ...
(Date:8/28/2014)... /PRNewswire-iReach/ -- Gateway Analytical announced today that they ... Annual Global Pharma Manufacturing Summit in ... The Global Pharma Manufacturing Summit offers a networking ... biologic pharmaceutical manufacturing. The conference is focused on ... such as the increasing pressure to grow and ...
(Date:8/28/2014)... Orthopaedics, the Official Joint Replacement Products of the PGA TOUR ... to golf fans at the next stop of the FedEx ... company,s fan destination – "The Stryker Mobility Zone" – will ... TPC Boston in Norton, MA starting ... the Deutsche Bank Championship, Stryker will be providing golf fans ...
Breaking Medicine Technology:Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 2Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 5
... Dec. 12, 2010 Pfizer Inc. (NYSE: ... vaccine [13-valent, adsorbed]) was introduced into the first childhood ... world under the auspices of the Advance Market Commitment ... is an innovative program which involves private-public partnerships to ...
...  The Office of Inspector General for the Export-Import Bank ... Miami resident Yader A. Padilla, 59, was sentenced to 24 ... U.S. District Judge Paul C. Huck in U.S. District Court ... his role in defrauding the Ex-Im Bank.  Padilla had previously ...
Cached Medicine Technology:Young Children In Developing World Receive Accelerated Access to Pfizer's Prevenar 13 Vaccine 2Young Children In Developing World Receive Accelerated Access to Pfizer's Prevenar 13 Vaccine 3Young Children In Developing World Receive Accelerated Access to Pfizer's Prevenar 13 Vaccine 4Young Children In Developing World Receive Accelerated Access to Pfizer's Prevenar 13 Vaccine 5Distributed by the Export-Import Bank of the United States On Behalf of the Independent Office of Inspector General 2
(Date:8/28/2014)... glue directly on the nerve stumps, but this method ... glue to easily invade the nerve ends. Ordinarily, nerve ... the nerve ends into the conduit because the nerve ... and co-workers from the General Hospital of Chinese PLA ... defined the best parameters for its use through in ...
(Date:8/28/2014)... can be treated with nasal septum cells. Researchers at ... that cells taken from the nasal septum are able ... and can thus repair articular cartilage defects. The nasal ... joint environment is associated with the expression of so-called ... has published the research results together with the ...
(Date:8/28/2014)... One in every 200 Ontarians has been diagnosed with ... living with the disease increasing by 64 per cent ... researchers at the Institute for Clinical Evaluative Sciences (ICES), ... Ottawa Hospital Research Institute. That puts Ontario in the ... The study, published this week in Inflammatory Bowel ...
(Date:8/28/2014)... rheumatoid arthritis patients in the study who were on ... not take them as prescribed in the first six ... from 60 hospitals around the UK involved in the ... for Genetics and Genomics at The University of Manchester, ... the drugs correctly, known as ,non-adherence, reduced their effectiveness ...
(Date:8/28/2014)... 28, 2014 BCC Research ( http://www.bccresearch.com ... SYSTEMS: TECHNOLOGIES AND GLOBAL MARKETS , the global market ... in 2013. Driven by the need for replacement of ... in emerging geographies, the market is expected to grow ... (CAGR) of 8.5% from 2013 through 2018. , While ...
Breaking Medicine News(10 mins):Health News:From nose to knee: Engineered cartilage regenerates joints 2Health News:Ontario has one of the highest rates of IBD in the world 2Health News:Arthritis patients failing to take expensive medication, according to new research 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 3
... of pain patients in light of federal pain management policy ... Academy of Pain Medicine (AAPM) will brief congress today on ... , The crisis of under-treated pain extends well beyond ... is now a social issue with major economic and political ...
... HARBIN, China, Nov. 8 /Xinhua-PRNewswire-FirstCall/ -- China Sky ... marketer and,distributor of pharmaceutical, medicinal and diagnostic products ... previously announced amendment to,the Company,s Form 10KSB for ... in completing the Form 10QSB for the three, ...
... Performance Continues; Stockholders Approve Sale of Nabi ... Biologics ... NABI ) today announced its third quarter,financial results. The company ... the quarter ended September 29, 2007, which included,$7.5 million, or $0.12 ...
... declines stopped in 2004, CDC report shows , , THURSDAY, Nov. ... adults were current cigarette smokers, a percentage that hasn,t changed ... finding suggests that the previous seven-year decline has stalled, says ... Mortality Weekly Report , published by the U.S. Centers for ...
... Inc.,(Nasdaq: VTIV ) today announced that David ... the 2007 Credit Suisse Healthcare Conference,taking place in ... will,feature companies spanning all sectors of healthcare, with ... will take place on Tuesday, November 13 at ...
... and Ohio Farm Bureau,Federation (OFBF) have announced a ... OFBF,s more than 230,000 members. Effective January ... to,Medical Mutual,s SuperMed provider network, the most comprehensive ... in Ohio. Medical,Mutual and OFBF have worked together ...
Cached Medicine News:Health News:National physician organization supports Capps-Rogers Bill at today's congressional briefing 2Health News:China Sky One Medical Completes Previously Announced Amendment to 2006 Form 10KSB 2Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 2Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 3Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 4Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 5Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 6Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 7Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 8Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 9Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 10Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 11Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 12Health News:U.S. Smoking Rates Stall 2Health News:inVentiv Health to Present at the 2007 Credit Suisse Healthcare Conference 2Health News:Ohio Farm Bureau Health Plan Awarded to Medical Mutual of Ohio 2Health News:Ohio Farm Bureau Health Plan Awarded to Medical Mutual of Ohio 3
... Bypass 6200: Direct connection to ... OCD870C CGA 870 Regulator , ... OCD2001-18 Carrying Pouch , OCD2001-11 ... M-6 Cylinder Carrying Bag , ...
... CVD Diamond Knives. New advancements in diamond ... to be used at a more economical ... reapproximation, enhances healing, and insures a superior ... and are available in a variety of ...
The New Easy-To-Use Disposable Diamond Knife Cleaning System Can Remove Even Baked-On Debris In Seconds. It Is Much More Effective Than Steam Or Blocks Of Styrofoam, Much Safer For Employees As Wel...
... To Safely And Easily Cut Foldable ... Designed To Cut And Remove Even ... With One Instrument.,New Miniaturized Profile Allows ... For Explantation Of A Silicone Lens.,Available ...
Medicine Products: